Table 3.
Year | Author | N | Indication | Initial ERCP | Techniques | Technical success | Clinical Success | Complication |
---|---|---|---|---|---|---|---|---|
2006 | Kahaleh et al. [28] | 13 | Both | Sb | 11 R*; 1 T | 12/13 (92.3%) | 12/12 (100%) | 1/13 (7.7%) |
2007 | Bories et al. [38] | 11 | Both | Sb | T | 10/11 (91%) | 10/10 (100%) | 4/11 (36%) |
2007 | Will et al. [7] | 10# | Both | Sb | T | 9/10 (90%) | 8/9 (88.9%) | 1/8 (12.5%) |
2009 | Maranki et al. [12] | 35 | Both | Sb (mostly) | 24 R; 3 T; 2 A | 29/35 (83%) | 29/35 (83%) | 5/35 (14.3%) |
2009 | Horaguchi et al. [14] | 7 | M | Sb | T | 7/7 (100%) | 6/7 (86%) | 1/7 (14.3%) |
2011 | Park do et al. [11] | 31 | Both | Sm | T | 31/31 (100%) | 27/31 (87%) | 5/31 (16%) |
2011 | Weilert et al. [39] | 6 | B | n/a | 4 A; 2 R | 6/6 (100%) | 6/6 (100%) | 1/6 (17%) |
2012 | Iwashita et al. [36] | 9 | Both | Sm | R | 4/9 (44%) | 4/4 (100%) | 1/9 (11%) |
| ||||||||
Total | 123 | 63 T; 46 R; 6 A | 109/123 (88.6%) | 103/109 (94.5%) | 19/123 (15%) |
EUS-CP: endoscopic-ultrasound-guided cholangiopancreatography, N: number of patients, B: benign, M: malignant, Sb: subsequent day, Sm: same day/session, D: ductography, T: transluminal, R: rendezvous, A: antegrade, n/a: not applicable/mentioned. *In few cases stents might have been placed antegrade. #10 interventions in 8 patients.